The role of RAS oncogenes in controlling epithelial mechanics release_57jpynsnp5h4fozhxdnjntcc44

by Agata Nyga, Sushila Ganguli, Helen K Matthews, Buzz Baum

Published .

2022   Volume 33, Issue 1, p60-69

Abstract

Mutations in RAS are key oncogenic drivers and therapeutic targets. Oncogenic Ras proteins activate a network of downstream signalling pathways, including extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3-kinase (PI3K), promoting cell proliferation and survival. However, there is increasing evidence that RAS oncogenes also alter the mechanical properties of both individual malignant cells and transformed tissues. Here we discuss the role of oncogenic RAS in controlling mechanical cell phenotypes and how these mechanical changes promote oncogenic transformation in single cells and tissues. RAS activation alters actin organisation and actomyosin contractility. These changes alter cell rheology and impact mechanosensing through changes in substrate adhesion and YAP/TAZ-dependent mechanotransduction. We then discuss how these changes play out in cell collectives and epithelial tissues by driving large-scale tissue deformations and the expansion of malignant cells. Uncovering how RAS oncogenes alter cell mechanics will lead to a better understanding of the morphogenetic processes that underlie tumour formation in RAS-mutant cancers.
In text/plain format

Archived Files and Locations

application/pdf  1.1 MB
file_voito4dw3vg7jpqlljd3c3yi2e
www.cell.com (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2022-09-26
Language   en ?
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: b72e53e4-928c-4b99-aeae-33e8a6810774
API URL: JSON